
October 9, 2023
RegMed Investors (RMi) Closing Bell: sector interruptus
October 9, 2023
RegMed Investors’ (RMi) pre-open: who’s flashing buy signals or not?
October 6, 2023
RegMed Investors (RMi) Closing Bell: a “good news is bad news” conundrum
October 6, 2023
RegMed Investors’ (RMi) pre-open: searching for an equilibrium
October 5, 2023
RegMed Investors (RMi) Closing Bell: I won’t apologize for providing need-to-know “facts in evidence”
October 5, 2023
RegMed Investors’ (RMi) pre-open: What went up with ceremony, went down with disdain follows with a maybe opposite effect
October 4, 2023
RegMed Investors (RMi) Closing Bell: not in the cards for cell and gene therapy sector
October 4, 2023
RegMed Investors’ (RMi) pre-open: a bounce back?
October 3, 2023
RegMed Investors (RMi) Closing Bell: When you’re on a roller coaster
October 3, 2023
RegMed Investors’ (RMi) pre-open: frothy markets and a slippery sector
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors